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Background: Evidence-based practice refers to building clinical decisions on credible research evidence, professional experience,
and patient preferences. However, there is a growing concern that evidence in the context of electronic health (eHealth) is not
sufficiently used when forming policies and practice of health care. In this context, using evaluation and research evidence in
clinical or policy decisions dominates the discourse. However, the use of additional types of evidence, such as professional
experience, is underexplored. Moreover, there might be other ways of using evidence than in clinical or policy decisions.
Objective: This study aimed to analyze how different types of evidence (such as evaluation outcomes [including patient
preferences], professional experiences, and existing scientific evidence from other research) obtained within the development
and evaluation of an eHealth trial are used by diverse stakeholders. An additional aim was to identify barriers to the use of evidence
and ways to support its use.
Methods: This study was built on a case of an eHealth trial funded by the European Union. The project included 4 care centers,
2 research and development companies that provided the web-based physical exercise program and an activity monitoring device,
and 2 science institutions. The qualitative data collection included 9 semistructured interviews conducted 8 months after the
evaluation was concluded. The data analysis concerned (1) activities and decisions that were made based on evidence after the
project ended, (2) evidence used for those activities and decisions, (3) in what way the evidence was used, and (4) barriers to the
use of evidence.
Results: Evidence generated from eHealth trials can be used by various stakeholders for decisions regarding clinical integration
of eHealth solutions, policy making, scientific publishing, research funding applications, eHealth technology, and teaching.
Evaluation evidence has less value than professional experiences to local decision making regarding eHealth integration into
clinical practice. Professional experiences constitute the evidence that is valuable to the highest variety of activities and decisions
in relation to eHealth trials. When using existing scientific evidence related to eHealth trials, it is important to consider contextual
relevance, such as location or disease. To support the use of evidence, it is suggested to create possibilities for health care
professionals to gain experience, assess a few rather than a large number of variables, and design for shorter iterative cycles of
evaluation.
Conclusions: Initiatives to support and standardize evidence-based practice in the context of eHealth should consider the
complexities in how the evidence is used in order to achieve better uptake of evidence in practice. However, one should be aware
that the assumption of fact-based decision making in organizations is misleading. In order to create better chances that the evidence
produced would be used, this should be addressed through the design of eHealth trials.
(J Med Internet Res 2020;22(8):e17718) doi: 10.2196/17718
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Evidence-based medicine has taken a central role in health care,
aiming to increase the quality of clinical practice. In the medical
domain, it is conceptualized as building clinical decisions on
credible research evidence, professional experience and
judgement, and patient preferences [1-3]. This trend has also
risen in the evaluation and implementation of information and
communication technologies (ICT) in health care (electronic
health [eHealth]) [4,5]. Similar to conventional medicine,
decision making in the implementations of eHealth solutions
should “rely on explicit evidence derived from rigorous studies
on what makes systems clinically acceptable, safe, and effective
– not on basic science or experts alone” [6]. Hence, evidence
should have utility in these decisions (ie, it should be usable
and used). However, there is a growing concern that scientific
evidence on whether eHealth works and is safe to use is not
sufficiently used when forming health care policies and practice
[4,7-11].
Evidence produced by evaluations dominates the discourse
related to the evidence-based practice of eHealth
implementations [7,12,13]. This emphasis and the strategies to
support the use of this type of evidence can be seen through the
scholarly discussions and sound methodological base developed
in the form of evaluation guidelines, standard measures, and
evaluation frameworks [7,13,14]. However, evidence-based
practice includes additional types of evidence, such as
professional experience and judgement, existing scientific
evidence from other research, and patient preferences [1,2,7].
The use of these types of evidence generated through testing
and implementing eHealth solutions is underexplored, leading
to a lack of supporting strategies.
When the expectation is to use the evaluation evidence in
making decisions regarding clinical implementations of eHealth
[5], it refers to instrumental use, which is the direct use of the
information in decision making and taking action, in order to
change existing practice [15-19]. When evidence is not used
instrumentally, it is referred to as a waste of resources and
efforts contributing to the phenomenon of “pilotism” (remaining
in a pilot state and not taken to integration) [20,21]. However,
previous research has identified a number of other ways of
evidence use [15,17-19,22,23]. Conceptual use refers to a
nondirect use of information and perspectives to enhance
understanding. Strategic or symbolic use happens when the
evidence is brought up to support or confront an existing idea
or decision. To the best of our knowledge, the different ways
of evidence use (instrumental, conceptual, or symbolic) in the
context of eHealth have not been addressed by previous
research. Discussions limited to instrumental use potentially
provide a too narrow view of actual evidence use in practice.
Furthermore, the considered users of evidence in the context of
eHealth are usually limited to policy makers or health care
professionals. However, eHealth is a multi-disciplinary field
[14], and there might be more beneficiaries of the evidence.
Exploring the types of evidence and the ways different actors
use it can be worthwhile to support the uptake of evidence in
the context of eHealth.
The purpose of this study was to analyze how different types
of evidence (such as evaluation outcomes [including patient
preferences], professional experiences obtained within the
development and evaluation of an eHealth trial, and existing
scientific evidence from other research) are used by diverse
stakeholders. An additional aim was to identify barriers to the
use of evidence and ways to support its use.
Methods
Context
This study was built on a case of a multinational and
interdisciplinary European Union–funded project (for anonymity
reasons, called “Alpha” in this paper). It was a
nonpharmacological eHealth trial aimed at improving quality
of life and increasing the independence of elderly with mild
cognitive impairment and mild dementia. The Alpha trial
introduced a case manager role and an ICT platform that
consisted of web-based physical and cognitive exercise programs
and an activity monitoring device to be used at home. As such,
innovations were introduced on both the service model and
technological levels.
The Alpha approach was implemented and tested in 4 countries.
The project involved 8 partners: 4 care centers (in the
aforementioned countries), 2 research and development
companies that provided the eHealth solutions, and 2 science
institutions. The trial lasted for 6 months. The evaluation
included a number of variables, such as clinical efficacy, quality
of life, patient adherence to technology, patient and health care
professional’s satisfaction, process effectiveness, and a
cost-benefit analysis. Clinical professionals were asked to collect
patient data using a number of standardized and custom-made
questionnaires, as well as to register some data in the registries
in Excel files. The evaluation was performed at the end of the
project and was finalized in June 2018. During the evaluation,
several project partners were charged analyzing the different
variables. As it frequently happens in multinational projects,
the evaluation had to overcome several practical circumstances
such as ethical approvals and systems integration issues that
delayed patient recruitment and the start of the trial. This created
a situation in which the trial time had to be shortened for some
patients, resulting in a smaller dataset than planned.
Data Collection
The evidence considered in this study included evaluation results
(including patient preferences) and professional experiences
from the Alpha trial as well as existing scientific evidence from
other research. Data were collected through 9 semistructured
interviews with all the partners involved in the Alpha project
(4 care centers, 2 research and development companies that
provided the eHealth solutions, and 2 science institutions) that
were conducted 8 months after the evaluation was concluded.
The stakeholders were delimited to the partners of the Alpha
project, since they had deep knowledge and experience from
the trial and they were the primary candidates to consider using
the evidence developed. However, the funding institution did
not require the project partners to use evidence from the Alpha
project.
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The interviewee selection followed the principles of purposive
sampling [24] and involved the key members of the Alpha teams
in every country (see Table 1). At least one interview per partner
was conducted. The interviewees were in a position to either
use the evidence directly in making decisions that change
practice (clinical, technological, scientific) or to decide whether
the evidence is worthy of suggesting or presenting to the
decision makers in the organizations. The positions of the
interviewees and the industry of their work are presented in
Table 1. All the interviews lasted one hour, were conducted via
Skype, were recorded, and were transcribed.
Table 1. Interview respondents.
Interviewee occupationStakeholders
Care centers
Clinical neuropsychologistCare center 1
Quality directorCare center 2
Senior physicianCare center 2
Head of eHealtha researchCare center 3
Project managerCare center 4
Research and development companies
Coordinator of the eHealth groupResearch and development company 1
Project manager and scientific coordinatorResearch and development company 2
Science institutions
Director of the research centerScience institution 1
Scientific coordinatorScience institution 2
aeHealth: electronic health.
The interviews followed a guide structured around the
components of evidence use [18,19,25], such as evidence users,
types of impact, evidence already used (and useful) depending
on the agenda of the stakeholder, agenda or purpose, quality of
research, methodological credibility, relevance and timing for
the organization to use the evidence, presentation of the results,
and future plans in relation to the evidence.
Data Analysis
For every stakeholder, we analyzed the following: (1) the types
of activities and decisions that were made after the Alpha project
ended; (2) the types of evidence (evaluation results from the
trial [including patient preferences], professional experiences,
or existing scientific evidence from other research) that were
used for those activities and decisions, based on the definitions
of evidence [1]; (3) in what way the evidence was used
(instrumental, conceptual, symbolic) [15,17-19,22]; and (4)
barriers to the use of evidence. Instrumental use of evidence
was assumed if the evidence obtained from the trial had a direct
impact on practice decisions. Conceptual use of evidence was
assumed when the evidence from the trial was used indirectly
in ways that impacted the understanding, attitudes, and
knowledge of the stakeholders but did not cause a change in
practice. Symbolic use of evidence was concluded when the
stakeholder had used evidence in confirming previous decisions.
If necessary, the data were validated with professionals from
the Alpha partners.
The findings were grouped by the types of activities and
decisions made by the stakeholders using evidence from Alpha.
For each activity or decision, the use of evidence is discussed.
Results
At 8 months after the Alpha project ended, partners in the project
(stakeholders) used evidence in the following decisions and
activities: (1) integrating or abandoning the Alpha approach in
clinical practice, (2) publishing results from the Alpha study,
(3) applying for new research funding, (4) supporting regional
policymaking, (5) improving technology, and (6) teaching
students and health care professionals. Next, the ways that
evidence were used by the stakeholders in every decision and
activity are explained.
Integrating the Alpha Approach Into Clinical Practice
At the time of this study, 2 of the 4 care centers had decided to
integrate the Alpha approach into clinical practice (care centers
1 and 2). In these care centers, the decision was mainly informed
by the evidence from professional experiences. The health care
professionals decided to adopt the Alpha approach based on
their experiences with usability and adherence to the technology,
as well as on patient satisfaction with the service. At the time
of the decision, the evaluation results were not available yet.
However, the professionals relied on their experience and the
existing scientific evidence from other research that
demonstrated that technologies and care models similar to Alpha
can be beneficial for the patients targeted. The existing research
was quite explicit on the benefits of physical and cognitive
exercise (with and without the help of technology) for patients
with cognitive impairments.
Specific clinical data are not a reason to not try to
implement this model. Existing research can provide
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us such information. <…> Data related to adherence
are enough to be interpreted as a useful model for
these patients. [Care center 1, clinical
neuropsychologist]
The decisions to adopt the Alpha approach in care centers 1 and
2 were facilitated by the fact that resources for implementation
were available from regional policies supporting and financing
care models like Alpha. Care centers 1 and 2 planned to perform
deeper statistical analyses on the clinical outcomes, cost, and
savings. If a positive effect was found, the results would be
disseminated, which would support their decision to integrate
the Alpha approach in practice. Hence, in the case of care centers
1 and 2, professional experiences and existing scientific evidence
from other research were used instrumentally (directly in
decision making and action), while evaluation evidence was
used symbolically (to strengthen the already taken decision).
When the decision was made, we didn’t have any
results yet. <...> Our experience and preliminary
data showed that this model is quite good. <…>
Managers trusted our previous evaluations of similar
models and thought that it will be the same. <…> We
have to redo the economic evaluation to see how much
it actually costs and how much we save. [Care center
2, quality director]
Care center 3 planned to use the evaluation results to make a
decision regarding adopting the Alpha approach in its clinical
practice. The organization planned to present the evaluation
results to the board and express a need for an eHealth solution
like that tested in the Alpha project. Once approval from the
board is obtained, the technology can be purchased and
integrated in clinical practice. In this case, using the evaluation
results in decision making for practice improvement indicates
instrumental use.
Once we demonstrate that the results are OK, we are
in a position to escalate it to decision makers, and
we are able to incorporate it in our organization.
[Care center 3, Head of eHealth research]
Care center 4 decided to abandon the Alpha approach.
Professional experiences were the primary influence on this
decision. The concept was abandoned when the staff realized,
over the course of the trial, how many resources the new model
requires when applying it within the context of care center 4. It
was deemed not the right time for the concept to be adopted in
the organization. After the project finished, staff’s experiences
in the care process of Alpha were presented to management. In
the case of care center 4, professional experiences were used
instrumentally (directly in decision making and action).
We didn’t pay so much attention to the results of the
evaluation. We looked at what does it mean to work
with patients in a situation like that. <…> For
management, the descriptive conclusions were more
interesting than the analysis. [Care center 4, project
manager]
Publishing Results of the Alpha Project
Publishing the results from the Alpha project in scientific outlets
was initiated by almost all the partners of Alpha (except care
center 4). The care centers used the clinical outcomes, quality
of life, patient and employee satisfaction, and cost data in the
scientific publications. The research and development companies
used the adherence data and the feedback from patients and
health care professionals related to their specific technology.
Publishing the evaluation results helped these companies
strengthen their image by demonstrating a case of the technology
application in a real setting. In addition to the evaluation results,
the partners used the existing scientific evidence from other
research to build a case for research.
Since scientific publishing did not directly relate to decision
making in practice, such use of evaluation evidence and existing
evidence from other research was deemed conceptual.
Applying for New Research Funding
Most of the partners (care centers 1, 2, and 3; science
institutions; and research and development companies) used
Alpha evaluation results and professional experiences when
applying for further research funding. Evaluation outcomes,
experiences, and lessons learned in Alpha provided the basis
for the case and allowed ideas to be built that could be applied
in the next project. In such a case, Alpha evaluation results and
professional experiences did not change local practices but
increased the knowledge and understanding of the partners that
subsequently helped to develop better research ideas and
improve the design of the future studies. Hence, such use of
evaluation evidence and professional experiences was deemed
conceptual.
Supporting Regional Policy
Science institutions 1 and 2 and care centers 1, 2, and 3
presented Alpha results in regional policymaking activities as
a concrete local example of an eHealth-supported care model
within their regions. For this purpose, science institution 2 used
the managerial and economic evidence from the evaluation of
Alpha to demonstrate the possible impact of the eHealth solution
on the local care facility. In addition, science institutions 1 and
2 used the health care professionals’ feedback and perceptions
on working with Alpha in their local contexts to demonstrate
local applicability. Since the Alpha case served as an example
and was not meant to make decisions based on its results, such
use of evaluation evidence and professional experiences in
policymaking was deemed conceptual.
When you discuss a real case here in <region>, these
messages are stronger than to discuss cases in
<another country> or to say that literature says these
things are useful. [Science institution 2, scientific
coordinator]
Improving eHealth Technology
The evaluation results of Alpha helped research and
development company 2 in making decisions to improve its
technology. The company focused on the patients’ and health
care professionals’ feedback and preferences in relation to its
technology and initiated actions to improve it. Since the
evaluation evidence was used directly for decisions and action,
we classified such use of evidence as instrumental.
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Teaching Students and Health Care Professionals
Professional experiences with Alpha were used by science
institution 1 in teaching students and health care professionals.
Science institution 1 relied on the professionals’ feedback and
perceptions on working with Alpha in their local contexts, as
it demonstrates local applicability. Since the Alpha case served
as an example and decisions were not meant to be made based
on its results, such use of professional experiences in teaching
was deemed conceptual.
We used the experience with the care models as an
example in our courses. <…> We use it for
practitioners as a subject to discuss and reflect upon.
[Science institution 1, director of the research center]
Table 2 describes situations of using the evidence 8 months
after the project ended.
Table 2. Evidence use by different stakeholders.
Use of different types of evidence in making the decision or performing the activityDecisions taken and activities







ConceptualNo use observedConceptualPublish results
No use observedConceptualNo use observedSupport regional policy
Care center 2
InstrumentalInstrumentalSymbolicAdopt Alpha approach
ConceptualNo use observedConceptualPublish results
No use observedConceptualConceptualApply for research funding
No use observedConceptualNo use observedSupport regional policy
Care center 3
Instrumental (planned)Instrumental (planned)Instrumental (planned)Present Alpha approach to decision makers for full
implementation
No use observedNo use observedConceptualPublish results
No use observedConceptualConceptualApply for research funding
No use observedConceptualNo use observedSupport regional policy
Care center 4
No use observedInstrumentalNo use observedAbandon Alpha approach
Science institution 1
ConceptualNo use observedConceptualPublish results
No use observedConceptualNo use observedTeach students and health care professionals
No use observedConceptualNo use observedSupport regional policy
No use observedConceptualConceptualApply for research funding
Science institution 2
No use observedConceptualConceptualSupport regional policy
No use observedConceptualConceptualApply for research funding
ConceptualConceptualConceptualPublish results
Research and development company 1
ConceptualNo use observedConceptualPublish results
No use observedConceptualConceptualApply for research funding
Research and development company 2
No use observedInstrumentalInstrumentalImprove technology
ConceptualNo use observedConceptualPublish results
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Barriers to the Use of Evidence From the Alpha Trial
The first barrier to the use of evidence was related to the number
of variables included in the Alpha evaluation. In most of the
project locations, the scope of evaluation was deemed too
extensive (it included several variables related to clinical
efficacy, quality of life, patient adherence to technology, patient
and health care professionals’ satisfaction, a number of variables
to assess process effectiveness, and a cost-benefit analysis). The
interviewees indicated that the time needed to collect this
amount of data for every patient was too long. The clinicians
had to fit the data collection into their routine work during
meetings with the patients. Consequently, the clinicians were
making choices about which data to collect at a particular time.
Such trade-offs between data collection for the project and time
spent with a patient affected the completeness of data collected
and consequently the quality of evidence produced in the
evaluation.
When you want to monitor a lot of variables, it is
directly related to the time you need to spend with the
patients. <…> The target should be to optimize how
we collect the variables and information using not
that much time. [Care center 3, Head of eHealth
research]
The second barrier to the use of evidence was related to the
Alpha evaluation design when comparing before-after situations.
Some of the interviewees with a clinical background disagreed
that eHealth integration decisions can be purely based on hard
facts and not on evidence from the evaluation when making
such a decision. According to these respondents, novel
eHealth-supported care models tested during trials are complex
dynamic systems within the local context that vary, have
differences in culture, and are affected by social interaction.
Since these care models cannot be assumed as stable controlled
systems, the assumption of stability in the traditional before-after
measurement design of an eHealth trial provides less valuable
information for eHealth integration decisions to improve
practice. Additionally, such an evaluation design comparing
before-after situations does not maximize the potential to
enhance local learning. The interviewees suggested that people’s
experiences with an eHealth solution and process measures,
both captured continuously, could lead to iterative adaptation
and adjustment between the eHealth solution and the context.
Such iterative evaluation would provide higher value in these
eHealth integration decisions to improve practice.
If we own the evaluation, we would take repeated
measurements for improvement efforts and enhanced
learning, rather than traditional approaches. [Care
center 2, quality director]
Discussion
Principal Findings
In this study, we analyzed how different types of evidence,
generated through the development and evaluation of an eHealth
trial, are used by diverse stakeholders. This work demonstrated
that evidence from eHealth trials is used in more ways than
decision making regarding clinical integration or policymaking.
In addition, different stakeholders can use the evidence for
scientific publishing and dissemination, eHealth technology
improvement, research funding applications, and teaching.
We found that professional experiences seem to have more
influence over decisions regarding eHealth integration into
clinical practice than formal evaluations and research. Learning
whether and how an eHealth solution could fit within the local
context provides key information for local decision making. If
the design of an eHealth trial fails to create conditions for
professionals to gain experiences, it might prevent learning and
obtaining evidence that are crucial to increase the success rate
of eHealth trials in their post-pilot phase and reduce “pilotism”
[5,20]. Moreover, professional experiences from eHealth trials
provide evidence that is valuable for the greatest variety of
activities that include disseminating knowledge in various
formats, policymaking, teaching, and providing feedback for
technology improvement. Evaluation evidence might mostly
be valuable for scientific publishing. Existing scientific evidence
from other research is another type of evidence that can help to
make decisions when it comes to integrating eHealth solutions
into clinical practice. However, contextual relevance (eg,
location, disease) matters.
To support the use of evaluation evidence, one could consider
assessing a few, rather than a large number of, variables during
an evaluation. It can help ensure the quality of data collected,
preventing from making trade-offs between the time required
and quality of the data. Additionally, shorter iterative cycles of
evaluation could create better possibilities for health care
professionals to gain more experience and use it as evidence in
decision making regarding integration of eHealth solutions.
Professional experiences could enhance evidence when relevant
professionals are included and accumulate experience during
eHealth trials. Such an approach could increase the degree of
learning and chances that the eHealth solution would be
integrated into practice and reach sustainability. Existing
scientific evidence collected from previously conducted projects
or initiatives in the same location as an eHealth solution is
implemented can support decisions regarding eHealth
integrations better than scientific evidence obtained from other
locations. Research evidence produced in other contexts can be
problematic for direct translation into making such decisions.
However, it has value for scientific dissemination.
Limitations
The findings of this study were based on a specific innovation
research project funded by the European Union. The interviewee
sample was delimited to the partners of the project, since they
had deep knowledge of the project and its results and were in
the favorable position to use the evidence obtained. However,
perspectives of the funding agency, industry, or governments
could be a valuable avenue for further research. Similarly,
evidence produced in other settings and study designs could
provide a different view of the use of evidence. Furthermore,
the study captured the situation 8 months after the Alpha project
was finished. However, the use of evidence might be more
extensive in later stages due to the so-called “gestation period”
[25].
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Comparison With Prior Work
Previous research on evidence-based practice usually described
clinical implementations and policymaking [5,7] as evidence
use in the context of eHealth. By focusing on a wider ecosystem
of stakeholders than the traditional focus on health care
providers and policymakers, our work identifies more uses of
evidence, such as scientific publishing and dissemination,
eHealth product and service improvement, applying for research
funding, and teaching. Furthermore, we analyzed the use of
additional types of evidence [1] such as professional experiences
in addition to the traditional focus on evidence generated by
evaluations and research [7,12,13].
Our study shows that the typical discourse on the instrumental
use (in making decisions) of evidence (and lack of it) [5] does
not sufficiently reflect the actual use of evidence in the context
of eHealth. Evidence also serves the stakeholders conceptually
(increasing knowledge and understanding) and symbolically
(supporting already taken decisions) [15,17-19,22]. This
suggests that evidence created through eHealth trials can have
utility beyond decision making in clinical implementations of
eHealth solutions or policymaking. Therefore, evidence that is
not used instrumentally might not be a waste of resources and
effort (the problem of so-called “pilotism”), as frequently judged
by scholars [5,20]. Viewing the use of evidence through different
users and the ways of using it can reveal the actual ways in
which evidence from a trial is used, help commissioning bodies
have realistic expectations on the influence trials can have, and
help to design better trials.
Our study indicates that experiences in eHealth trials matter
more than facts when it comes to how evidence is used for
eHealth integration. The reason for this could be that “hard
facts” from evaluation are difficult to straightforwardly
implement in a complex health care reality [26,27]. Although
it is attractive to think about organizations as rationale organisms
and systems [5,28], organizations are rather characterized by
decisions and actions that are far from rational. Instead, personal
incentives, organizational culture, and other more subjective
fields come into play when explaining how decisions are made
and organizations develop [27,29,30]. Hence, we believe that
the designers of eHealth trials could benefit from understanding
how learning and continuous improvement are created and how
knowledge development occurs in contemporary health care
organizations. In other words, these fields could explain why
opinions and subjective knowledge are more important than
“hard facts” from an evaluation.
We identified a number of strategies to support the use of
evidence in practice in the context of eHealth trials. First, we
suggest focusing on a smaller number of variables during
evaluation, to ensure the quality of collected data. Such a
strategy is contradictory to the ever-expanding evaluation
frameworks that include a growing number of variables (eg,
[31,32]) and arguments that evaluations should aim to capture
as wide an array of outcomes as possible [13]. Second,
alternative designs to eHealth evaluation have been discussed
in prior research (eg, [14,33]). Our study showed that such
designs leading to shorter cycles of evaluation and enabling
learning, iteration, and forming experiences that can support
decisions could be more beneficial in improving the practice of
different stakeholders [34-36]. Failure to produce timely results
for decision making is among the barriers to the use of evidence
identified by previous research [26].
Conclusions
We conclude that various stakeholders (such as care centers,
research and development companies, science institutions)
benefit from evidence differently. Therefore, the delimited focus
of research on decision making in clinical settings or
policymaking does not capture the actual beneficiaries and
realities of evidence use. In addition, when making decisions
regarding improving practice, stakeholders do not necessarily
rely on the factual evidence produced by evaluations. We
conclude that, in the context of eHealth, professional experiences
seem to have more influence over decisions than formal
evaluations and research. Hence, we suggest that scientific and
practical discussions around evidence-based practice in the
context of eHealth should include all sorts of evidence
(evaluation evidence, professional experiences, existing
scientific evidence from other research, and patient preferences).
Additionally, it could be beneficial to have an in-depth view on
how the evidence is used. This could help expand the
conventional focus on clinical settings or policymaking and the
direct use of evidence produced by research or evaluation when
making decisions. Initiatives to support and standardize
evidence-based practice in the context of eHealth should take
these complexities into consideration to achieve better uptake
of evidence in practice.
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